To assess the impact of ZNF432 overexpression in a cellular model of high-grade serous ovarian cancer, we chose the ovarian cancer cell line COV362 and an Olaparib-resistant version (COV362-R). This evidence concerns the gene ZNF432 and ovarian carcinoma.